PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
2207116-10	1990	The action of ALP is consistent with a mechanism in which ALP interacts with a transmembrane portion of the sugar transport molecule resulting in a competitive displacement of D-glucose or cytochalasin B from the cytosolic facing side of the transport molecule.	Glucose	176-185	ATHS	Homo sapiens	14-17	
9185163-6	1997	While the activity of ALP of cerebral endothelial cells was maintained at the control level, we found a significant decrease in the gamma-GT activity from 3.8 +/- 1.3 to 1.09 +/- 0.3 U/mg protein after 3 h of hypoxia in the presence as well as in the absence of glucose.	Glucose	262-269	ATHS	Homo sapiens	22-25	
2207116-7	1990	ALP acts as a competitive inhibitor of exchange L-glucose transport, of CCB binding to the glucose transporter and of D-glucose inhibition of CCB binding to the transporter.	Glucose	48-57	ATHS	Homo sapiens	0-3	
2207116-7	1990	ALP acts as a competitive inhibitor of exchange L-glucose transport, of CCB binding to the glucose transporter and of D-glucose inhibition of CCB binding to the transporter.	Glucose	118-127	ATHS	Homo sapiens	0-3	
2207116-10	1990	The action of ALP is consistent with a mechanism in which ALP interacts with a transmembrane portion of the sugar transport molecule resulting in a competitive displacement of D-glucose or cytochalasin B from the cytosolic facing side of the transport molecule.	Glucose	176-185	ATHS	Homo sapiens	58-61	
34486387-6	2021	Indicators of osteogenic differentiation were all down-regulated by 40mM/L high glucose, including alkaline phosphatase(ALP) activity, runt-related transcription factor 2(RUNX2), and osteopontin(OPN) gene expression and Wnt signaling pathway.	Glucose	80-87	ATHS	Homo sapiens	120-123	
31080819-8	2019	Results: SCAPs in 25mmol/L glucose group expressed the maximum proteins of RUNX2 and ALP as compared with those in 5, 10, and 15 mmol/L groups.	Glucose	27-34	ATHS	Homo sapiens	85-88	
30894315-11	2019	Furthermore,EPO alleviate high glucose(30 mM) induced suppression of osteogenic differentiation ability in PDLSCs, as evidenced by the up-regulated mRNA and protein expression of Runx2 and Osterix and increased ALP activity.	Glucose	31-38	ATHS	Homo sapiens	211-214	
31080819-10	2019	ALP assay, alizarin red staining, real-time RT-PCR, and western blot showed 25 mmol/L high glucose can obviously enhance the odonto/osteogenic capacity of SCAPs.	Glucose	91-98	ATHS	Homo sapiens	0-3	
28525946-13	2017	From in vitro investigation, we found that the high-glucose (HG), high-lipid (HL), and beta-glycerophosphate (beta-GP) considerably increased the total calcium content, ALP activity, and expression of osteogenic markers in vascular smooth muscle cells (VSMCs).	Glucose	52-59	ATHS	Homo sapiens	169-172